##
##
||Page|
|---|---|
|Report of the Trustees and Strategic Report|1 - 12|
|Report of the Independent Auditors|13-16|
|Statement of Financial Activities|17|
|Balance Sheet|18|
|Cash Flow Statement|19|
|Notes to the Cash Flow Statement|`20`|
|Notes to the Financial Statements|21 - 28|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||Director|Integrated|Finance and|Capital|Workforce|
|---|---|---|---|---|---|
|Committees|Appointments|Governance|Audit|Development|and|
||||||Remuneration|
|Mr C Barratt|Chair|x|x||x|
|Mr C Bridge||Chair|X|||
|Ms C Dodwell||||Chair||
|Mr R G Hammond|X|||X|Chair|
|Dr C Since|X|x||||
|Mr L Marlow|||Chair|X|x|
|Ms S Watson||x||||
|Mr N Smillie||X (to May)||||
|Mr A Appleton||||X||
|Mr M Manninq||x||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||**2022**|2021|
|---|---|---|---|
|||**Unrestricted**|Unrestricted|
|||**funds**|funds|
|||£|£|
||Notes|||
|**INCOME**||||
|Donations and legacies|3|0|3,483|
|Investment income|4|0||
|**Incoming resources from charitable activities**||||
|Medical services provided
**Other income**|5|14,272,560
115,076|13,448,758
117,955|
|**Total income**||14,387,636|13,570,196|
|**EXPENDITURE**||||
|**Charitable activities**||||
|Medical services provided|6|14,249,702|14,224,294|
|**Total expenditure**||14,249,702|14,224,294|
|**NET (EXPENDITURE)/INCOME**||137,934|(654,098)|
|Total funds brought forward||6,380,810|12,090,140|
|**TOTAL FUNDS CARRIED FORWARD**||6,518,744|11,436,042|
##
|||**2022**|2021|
|---|---|---|---|
|||**Unrestricted**|Unrestricted|
||Notes|**funds**
£|funds
£|
|**FIXED ASSETS**||||
|Intangible assets|13|7,726|15,471|
|Tangible assets|14|6,513,544|11,911,086|
|**Total** Fixed Assets||6,521,270|11,926,557|
|**CURRENT ASSETS**||||
|Stocks|15|313,565|280,419|
|Debtors: amounts falling due within one year|16|1,966,350|1,766,359|
|Cash at bank||767,843|459,820|
|||3,047,758|2,506,598|
|**CREDITORS**||||
|Amounts falling due within one year|17|(1,861,084)|(1,657,912)|
|**NET CURRENT ASSETS**||1,232,061|848,686|
|**TOTAL ASSETS LESS CURRENT LIABILITIES**||7,707,944|12,775,242|
|**CREDITORS**||||
|Amounts falling due after more than one year|18|(1,189,200)|(1,339,200)|
|**NET ASSETS**||6,518,744|11,436,042|
|**FUNDS**||||
|Unrestricted funds|`20`|6,518,744|11,436,042|
|TOTAL FUNDS||6,518,744|11,436,042|
##
##
||||||**2022**|2021|
|---|---|---|---|---|---|---|
|||||Notes|£|£|
|**Cash flow from operating **|**activities**||||||
|Net cash (used in)/provided|by operating activities|||a|308,022|(61,883)|
|**Cash flows from investing **|**activities**||||||
|Purchase of property, plant|and equipment||||(80,360)|(468)|
|**Net cash used in investing **|**activities**||||227,662|(468)|
|**Cash flows from financing **|**activities**||||||
|Loan drawn down|||||||
|**Net cash from investing activities**|||||||
|Change in cash and cash equivalents||in the reporting period|||308,022|(62,352)|
|Cash and cash equivalents|at the beginning||of the reporting||459,820|522,172|
|period|||||||
|**Cash and cash equivalents**
**at the **||**end of the reporting**||b|767,842|459,820|
|**period**|||||||
##
##
##
|||||||2022|2021|
|---|---|---|---|---|---|---|---|
|||||||£|£|
||Net (expenditure)/income|for reporting|period|(as per the||137,934|(654,097)|
||statement
of financial
activities)|||||||
||Amortisation
of intangible assets|||||7,745|10,605|
||Depreciation
charges|||||422,670|512,586|
||Interest received|||||||
||(Increase)/decrease
in stocks|||||(33,147)|72,770|
||Decrease/(increase)
in debtors|||||(40,466)|(526,100)|
||(Increase)
in prepayments|||||(159,525)|(3,603)|
||(Decrease)/increase
in creditors|||||203,171|426,956|
||Sales of lease of Bungalow||||||99,000|
||CBILS loan reduction over|1 year||||(150,000)||
||Purchase of Fixed assets|||||(80,360)||
||Net cash provided by operating activities|||||308,022|(61,883)|
|b.|ANALYSIS OF CASH AND|CASH EQUIVALENTS||||||
||||||2022|2021||
||||||£|£||
||Cash||||767,842|459,820||
##
||At||At 31|
|---|---|---|---|
||1 January|Cash flow|December|
||2022||2022|
||£|£|£|
|Net cash:||||
|Cash at bank|459,820|308,022|767,842|
|Bank Loan due in greater than one year||||
||459,820|308,022|767,842|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|**`3.`**|**DONATIONS AND LEGACIES**|||
|---|---|---|---|
|||**2022**|2021|
|||£|£|
||Legacies and Donations||3,483|
|**`4.`**|**INVESTMENT INCOME**|||
|||**2022**|2021|
|||£|£|
||Bank interest|||
##
##
|||**2022**|2021|
|---|---|---|---|
|||£|£|
|Medical services|provided|14,272,560|13,448,758|
||**Direct Medical**|**Direct Medical**|**Support costs**|**Support costs**|**Governance**|**Total**|Total|
|---|---|---|---|---|---|---|---|
|||**costs**|**(see **|**note 12)**|**Costs (see**|**2022**|2021|
||**(see note 7)**||||**note 8)**|||
|||£||£|£|£|£|
|Medical services|10,782,438||3,436,645||30,619|14,249,702|14,224,294|
|Provided||||||||
|**DIRECT COSTS OF**|CHARIT**ABLE ACTIVITIES**|||||||
||||||**2022**|2021||
||||||£|£||
|Staff costs|||||3,025,257|3,225,011||
|Direct medical costs|||||7,128,055|6,974,699||
|Insurance|||||294,796|576,609||
|Patient services|||||140,020|119,098||
|Medical Equipment Maintenance and Repair|||||194,310|325,364||
||||||10,782,438|11,220,781||
|**GOVERNANCE COSTS**||||||||
||||||**2022**|2021||
||||||£|£||
|Auditors' remuneration|||||30,619|27,122||
|**NET (EXPENDITURE)/INCOME**||||||||
|Net (expenditure)/income||is stated after charging/(crediting):||||||
||||||**2022**|2021||
||||||£|£||
|Amortisation of intangible||assets|||7,745|10,605||
|Depreciation of owned assets|||||422,670|512,586||
##
##
##
##
##
##
|||**2022**|2021|
|---|---|---|---|
|||£|£|
|Salaries and wages:
-
Nursing and other clinical staff||2,707,680|2,564,163|
|-|Housekeeping, catering and maintenance|511,061|496,264|
|-|Management and administration|1,288,326|1,223,899|
|||4,507,067|4,284,326|
|Wage|and salaries|4,068,916|3,868,175|
|Social|security costs|337,813|316,232|
|Pension costs||100,338|99,919|
|||4,507,067|4,284,326|
|||**2022**|2021|
|---|---|---|---|
|||**Number**|Number|
|£100,001|- £110,000||1|
|£110,001|- £120,000|||
||**2022**|2021|
|---|---|---|
|Nursing and other clinical|94|102|
|Management, clerical and domestic|98|97|
||192|199|
##
||**2022**|2021|
|---|---|---|
||£|£|
|Management|2,118,681|1,590,405|
|Finance|238,135|103,307|
|Information Technology|289,815|363,688|
|Property|790,014|918,992|
||3,436,645|2,976,392|
##
##
|**INTANGIBLE**
**FIXED ASSETS**||
|---|---|
||**Total**|
||**Software**|
||£|
|**COST**||
|At 1 January 2022|118,503|
|Additions||
|At 31 December 2022|118,503|
|**DEPRECIATION**||
|At 1 January 2022|103,032|
|Charge for year|7,745|
|At 31 December 2022|110,777|
|**NET BOOK VALUE**||
|At 31 December 2022|7,726|
|At 31 December 2021|15,471|
##
||||**Medical**||
|---|---|---|---|---|
||||**Equipment,**||
||**Freehold**
**land**|**Freehold**
**property**|**Fixtures,**
**Fittings,**|**Total**|
||||**Computer**||
||||**Equipment**||
||£|£|£|£|
|**COST**|||||
|At 1 January 2022|3,366,366|8,806,318|3,298,254|15,470,938|
|Additions|||80,360|80,360|
|Impairment|(1,776,199)|(4,646,485)||(6,422,684)|
|At 31 December 2022|1,590,167|4,159,833|3,378,614|9,128,614|
|**DEPRECIATION**|||||
|At 1 January 2022||1,367,452|2,192,400|3,559,852|
|Charge for year||83,197|339,473|422,670|
|Impairment||(1,367,452)||(1,367,452)|
|At 31 December 2022||83,197|2,531,873|2,615,070|
|**NET BOOK VALUE**|||||
|At 31 December 2022|1 590167|4076,636|846741|6513544|
|At 31 December 2021|3366,366|7,438,866|1 105854|11911086|
##
|||**2022**|2021|
|---|---|---|---|
|||£|£|
|Consumable|medical supplies|289,864|254,543|
|Pharmacy||23,700|25,876|
##
##
||**2022**|2021|
|---|---|---|
||£|£|
|Trade debtors|1,654,203|1,419,625|
|Prepayments and accrued income|312,146|346,734|
||1,966,349|1,766,359|
||**2022**|2021|
|---|---|---|
||£|£|
|Trade creditors|984,145|803,841|
|Social security and other taxes|105,189|97,810|
|Accruals and deferred income|621,750|606,261|
|CBILS Loan (Note 19)|150,000|150,000|
||1,861,084|1,657,912|
|||**2022**|2021|
|---|---|---|---|
|||£|£|
|CBILS|Loan (Note 19)|300,000|450,000|
|Lease|deposits|889,200|889,200|
|||1,189,200|1,339,200|
##
##
||**At**|**Incoming**|**Resources**|**Funds**|**Gains**|**At**|
|---|---|---|---|---|---|---|
||**January**|**Resources**|**Expended**|**transferred**|**and**|**December**|
||**2022**||||**Losses**|**2022**|
||£|£|£|£|£|£|
|**Unrestricted**|||||||
|**funds**|||||||
|General fund|**11,436,042**|14,387,636|14,249,703||-5,055,231|6,518,744|
|**Total Funds**|**11,436,042**|14,387,636|14,249,703||-5,055,231|6,518,744|
##
|**21.**|**ANALYSIS OF RESERVES**|||
|---|---|---|---|
|||**2022**|2021|
|||£|£|
||Total reserves|6,518,744|11,436,042|
||Less: Land and buildings|(5,089,370)|(10,228,158)|
||Add: Lease deposits relating to land and buildings|889,200|889,200|
||Freely available reserves|2,318,214|2,097,084|
|**22.**|**FINANCIAL INSTRUMENTS**|||
|||**2022**|2021|
|||£|£|
||Financial assets measured at amortised cost|2,422,046|1,879,444|
||Financial liabilities measured at amortised cost|2,323,344|2,293,041|
##